Sustainable and Inclusive Use of Alternative Proteins in Mediterranean Supply Chains (CIPROMED)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Bologna

About this trial

This study investigates the effects of foods enriched with alternative protein sources, including edible insects, microalgae, hemp, and legumes, on appetite regulation, satiety, food preferences, and metabolic health in healthy adults and individuals with overweight. The study is part of the CIPROMED project, which aims to support sustainable and circular food systems in the Mediterranean area.

The study consists of two phases. In the acute phase, participants will consume different protein-enriched bread products in a controlled setting following a randomized crossover design. Each participant will be exposed to multiple test conditions, allowing within-subject comparisons of postprandial responses. Outcomes assessed during this phase include satiety, hunger, food preference, craving, and short-term energy intake, measured using validated scales and dietary assessment tools.

In the chronic phase, participants will follow structured dietary interventions over a longer period within a Mediterranean dietary framework. Participants will be assigned to different dietary patterns including alternative protein-based foods and control products. This phase aims to evaluate the effects of repeated consumption of alternative protein sources on metabolic parameters, gastrointestinal tolerance, nutritional status, and behavioral responses.

The study aims to assess the acceptability and physiological effects of alternative protein sources and to compare their impact with that of traditional protein sources commonly used in Mediterranean diets.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Providing signed informed consent,

Being between 18 and 65 years of age,

Having a body mass index (BMI) within the normal range, defined as between 18.5 and 24.9 kg/m² or Having a body mass index (BMI) between 25.0 and 34.9 kg/m², inclusive, corresponding to the overweight category or, at most, class I obesity.

Disqualifiers

Positive and documented history of allergy to legumes, insects, microalgae, shellfish, mollusks, crustaceans, snails, insect venom, house dust mites, or any component (ingredient or additive) present in the food prototypes tested, or a confirmed or suspected diagnosis of Celiac Disease.

History of severe allergic reactions to any type of allergen.

Pregnancy or Breastfeeding

Trial design

Design model

Crossover

Treatments tested in this trial

  • Mediterranean Diet with Control Products (chronic phase)

    Other intervention

    Mediterranean diet including control foods such as legume-based bread and standard fish burger, consumed five times per week for a period of 2 months.

  • Mediterranean Diet with Insect Protein Bread (chronic phase)

    Other intervention

    Mediterranean diet including bread enriched with edible insect protein (Acheta domesticus), consumed five times per week over a 2-month intervention period.

  • Mediterranean Diet with Seaweed-Based Burger (chronic phase)

    Other intervention

    Mediterranean diet including a burger made from edible seaweed, consumed five times per week over a 2-month intervention period.

Treatment groups

40 Participants
are divided into 4 treatment groups
Group A: Control (A) to Insect Bread (B) SequenceExperimental treatment 2 interventions
Group B: Insect Bread (B) to Control (A) SequenceExperimental treatment 2 interventions
Group C: Control (A) to Seaweed Burger (C) SequenceExperimental treatment 2 interventions
Group D: Seaweed Burger (C) to Control (A) SequenceExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Postprandial Satiety Assessed by Visual Analogue Scales (VAS)

Subjective appetite sensations are assessed using a customized 100 mm Visual Analogue Scale (VAS). The scale evaluates four primary domains: hunger, fullness (satiety), desire to eat, and prospective food consumption. Participants mark a point on a 100 mm line anchored by "not at all" (0 mm) and "extremely" (100 mm). Total scores for each domain range from 0 to 100, where higher scores for satiety indicate a greater feeling of fullness, and higher scores for hunger indicate a greater urge to eat. Post-prandial ratings are measured at baseline and at specific intervals following the consumption of protein-enriched bread products.

Time frame
At each test session following product consumption (5-week period)
2

Food Preference and Craving Responses Assessed by HTAS, LFP, and Hedonic Scale

Food preference, motivation, and attitudes were assessed following consumption of different protein-enriched bread products using three distinct validated instruments: Health and Taste Attitude Scales (HTAS): The validated Italian version of the HTAS was used to evaluate psychological attitudes toward food. The questionnaire comprises six subscales divided into two dimensions: Health-related attitudes (General health interest, Light product interest, Natural product interest) and Taste-related attitudes (Craving for sweet foods, Pleasure orientation, Using food as a reward). 9-Point Hedonic Scale: Sensory liking of the test foods was evaluated using a 9-point scale ranging from 1 ('Extremely unpleasant') to 9 ('Extremely pleasant'). Leeds Food Preference Questionnaire (LFP): This psychometric tool was used to assess food motivation via food images. It measures two distinct components: 'Liking' (perceived pleasantness) and 'Wanting' (motivation to consume the food at testing).

Time frame
At each test session following product consumption (5-week period)
3

Fasting Blood Glucose

Fasting plasma glucose concentration, assessed following the dietary intervention with alternative protein sources. Unit of Measure: mg/dL

Time frame
At baseline, 2 months, and 4 months
4

Fasting Serum Insulin

Fasting serum insulin concentration measured following dietary interventions with alternative protein sources. Unit of Measure: µIU/mL.

Time frame
At baseline, 2 months, and 4 months

Secondary outcomes

1

Postprandial Energy Intake and Energy Compensation Assessed by 24-Hour Dietary Recall

Postprandial energy intake and energy compensation measured using 24-hour dietary recall following consumption of different protein-enriched bread products.

Time frame
Within 24 hours after each test session (5-week period)
2

Incidence of Adverse Events

Participants will complete a 72-hour recall questionnaire to document any adverse reactions they may have experienced following product consumption.

Time frame
Within 72 hours after each test session (5-week period)
3

Liver Fat Content and Hepatic Stiffness Assessed by FibroScan and Controlled Attenuation Parameter (CAP)

Liver fat content and hepatic stiffness measured using transient elastography (FibroScan) and Controlled Attenuation Parameter (CAP) to evaluate changes following dietary interventions with different protein sources.

Time frame
At baseline, 2 months, and 4 months
4

Gut Microbiota Composition

Gut microbiota composition assessed through analysis of fecal samples to evaluate changes following dietary interventions with different protein sources.

Time frame
At baseline and 4 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Bologna

Lead sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Collaborator

University of Turin, Italy

Collaborator

Azienda Usl di Bologna

Collaborator